kevin Chiang - Profile and Investment Details

Investor Profile

kevin Chiang is a Venture Capital, Private Equity Firm, Micro VC based in China with a diverse investment portfolio that includes companies such as Abbisko Therapeutics, Antengene Corporation, Sanyou MedicalHua Medicine, GenFleet Therapeutics, Xgene Pharmaceutical, Hanyu Medical, Regor Therapeutics, Eccogene, Alpha Biopharma, EOC Pharma Group, Ark Biosciences, CANbridge Pharmaceuticals, Asieris Pharmaceuticals, GeneQuantum Healthcare, Tisenc, Zai Lab, . Over time, kevin Chiang has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether kevin Chiang is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Events Services, Life Science, Biotechnology, Lending, Medical, Therapeutics, Media and Entertainment, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with kevin Chiang, as their portfolio suggests a familiarity and interest in this area.

Understanding kevin Chiang’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.